Knowledge Hub

Global Immunoglobulin Products Market to grow at a CAGR of 6.84% during 2016-2020

Press Release   •   Nov 11, 2016 05:10 EST

About Immunoglobulin Products

Immunoglobulins, also known as antibodies, are proteins that help neutralize foreign objects such as bacteria and viruses. They help recognize and bind to particular antigens. Based on the difference in the amino acid sequence in the fragment crystallizable (Fc) region of the antibody heavy chain, they can be categorized into the following isotypes: IgA, IgD, IgE, IgG, and IgM. In 1952, immunoglobulin products were used for the first time to treat immune deficiency. They can be administered by either the intravenous (IV) or subcutaneous (SC) route. Immunoglobulin products given intravenously usually contain IgG. Immunoglobulin products are used to treat primary antibody deficiency, complex immune deficiency disorders, and life threatening infections. Immunoglobulin therapeutic products help prevent infections, improving the quality of life and increasing life expectancy.

Technavios analysts forecast the global immunoglobulin products market to grow at a CAGR of 6.84% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global immunoglobulin products market for the period 2015-2020. To calculate the market size, the report considers revenue generated from the sales of immunoglobulin products used to treat various autoimmune and immunodeficiency diseases.

The market is divided into the following segments based on geography:

Americas

APAC

EMEA

Technavio's report, Global Immunoglobulin Products Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Download Sample Copy of Report at http://www.marketresearchreports.biz/sample/sample/711501

Key vendors

Baxalta

Biotest Pharmaceuticals Corp.

CSL Ltd.

Grifols SA

Kedrion SpA

Octapharma

Other prominent vendors

Abeona Therapeutics

Admabiologics

Anthera

Beijing Tiantan Biological Products (China)

Bharat Serums and Vaccines (India)

Bio Products Laboratory

China Biologic Products (China)

Emergent Biosolutions

Gliknik

Greencross

Hansamedical

Hualan Biological Engineering (China)

Immunomedics

Innate Pharma

Integrated Biotherapeutics

Janssen Pharmaceuticals

Kamada

LFB Group (France)

Mitsubishi Tanabe Pharma

Momenta Pharma

Patrys

Shanghai RAAS Blood Products (China)

Sichuan Yuanda Shuyang Pharmaceutical (China)

Sorrento Therapeutics

Market driver

Growing aging population

For a full, detailed list, view our report

Market challenge

High cost of therapy

For a full, detailed list, view our report

Market trend

Patient assistance programs

For a full, detailed list, view our report

Key questions answered in this report

What will the market size be in 2020 and what will the growth rate be?

What are the key market trends?

What is driving this market?

What are the challenges to market growth?

Who are the key vendors in this market space?

What are the market opportunities and threats faced by the key vendors?

What are the strengths and weaknesses of the key vendors?